Welcome to NorthCarolinaLifeScience.com
NorthCarolinaLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination North Carolina
Are you considering a move to North Carolina? Relocating your business to
North Carolina? Starting a company? Or just interested in North Carolina?
This section will answer many of your questions regarding the life science industry in North Carolina, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Osiris completes enrollment in first worldwide phase III stem cell trial Osiris Therapeutics announced that it has completed patient enrollment in its Phase III pivotal trial evaluating Prochymal for the treatment of steroid-refractory acute Graft versus Host Disease, a life threatening complication of bone marrow transplantation.
Osiris Therapeutics, Inc. December 04, 2008
- Texas Hospital Association endorses MedMined to fight hospital acquired infections Cardinal Health announced that the Texas Hospital Association has endorsed MedMined(TM) services from Cardinal Health as an effective tool to help combat health care associated infections, improve patient care and dramatically reduce infection-related costs.
Cardinal Health December 04, 2008
- AstraZeneca and POZEN announce PN 400 Phase III study results AstraZeneca and POZEN, co-development partner for the investigational compound PN 400, announced results from two Phase III studies, PN 400-301 and PN 400-302 comparing PN 400 to enteric-coated naproxen 500 mg. These studies were conducted by POZEN under an agreed Special FDA Protocol Assessment.
AstraZeneca December 03, 2008
- Isis Announces survival advantage in prostate cancer study Isis announced that OncoGenex Pharmaceuticals provided positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone compared to docetaxel and prednisone alone for first-line treatment of metastatic castrate resistant prostate cancer.
Isis Pharmaceuticals, Inc. December 03, 2008
- POZEN announces positive results for Its PN 400 phase 3 trials POZEN announced positive Phase 3 trial results for its PN 400 product candidate (enteric coated naproxen 500 mg and immediate release esomeprazole 20 mg) conducted by POZEN under an agreed Special Protocol Assessment with the FDA.
POZEN Inc. December 03, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About North Carolina's BioHistory
Why is there a biotechnology industry in North Carolina? Will the industry continue
to grow in North Carolina? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through North Carolina BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of North Carolina.
More...
BioEvolution Posters
More...
Celebrate Life: World AIDS Day 2008
December 1 is World AIDS Day; a time to celebrate the many lives saved by HIV prevention and treatment programs.
It also serves as a reminder that we all must do more - as individuals, communities, and as world citizens - to fight the spread
of HIV and AIDS.
Around the world, 33 million people are living with HIV with nearly 7,500 new infections occurring each day. An estimated 3
million people are now receiving antiretroviral treatment in low and middle-income countries.
More...
BioFact
(1985) - Mycogen scientists receive permission to test MVP, the first genetically engineered biopesticide to receive the EPA's stamp of approval.
It's a Small World
|
| |
Dust Pathogens
| |
Science Quote
"Science is the systematic classification of experience."
| - |
George Henry Lewes, English writer
|
|
(1817-78)
|
|
